Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Jewish Values Investors JLens Target Israeli Company
Teva to cut 14,000 jobs | Business | Chemistry World
Israel-based Teva to invest $42 mln in new drug plant in Bulgaria
Teva Pharmaceuticals Office Photos | Glassdoor
Teva moves to cut hundreds of manufacturing jobs in Israel | Fierce Pharma
Israel's Teva halts testing alternative use for migraine drug - Business - Haaretz.com
Israeli pharmaceutical giant Teva investigating bribery accusations in Romania | The Times of Israel
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
Teva expected to lay off about 25% of its Israeli employees
Pharmaceutical giant Teva to lay off employees at Israel branches - Israel News - The Jerusalem Post
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Teva firing 350 employees from Israeli production facility | Ctech
Teva Pharmaceuticals - Wikipedia
Israel's Teva donating potential COVID-19 treatment to US hospitals - ISRAEL21c
Israeli drug giant Teva to move offices to Tel Aviv - Israel News - The Jerusalem Post
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
An Israeli pharma champion sickens | The Economist
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Israel targets Teva over MS drug royalties
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
The Unlikely Source of a Healthtech Revolution - Bloomberg
Teva Israel enters medical cannabis market with new partnership | Reuters
